Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-008192

Coherus Oncology, Inc. · CHRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 12, 2015
Accepted (ET)
Nov 16, 2015 · 3:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF1Nov 12, 2015S3,000$27.2309D75,836D
Common Stock, $0.0001 par valueF2Nov 13, 2015S7,988$27.3762D67,848D
Common Stock, $0.0001 par valueF3Nov 13, 2015S4,012$27.929D63,836D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses